Back to Search
Start Over
Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations
- Source :
- Clinical Chemistry and Laboratory Medicine (CCLM). 58:1053-1062
- Publication Year :
- 2020
- Publisher :
- Walter de Gruyter GmbH, 2020.
-
Abstract
- Coronavirus disease 2019 (COVID-19) is the third coronavirus outbreak that has emerged in the past 20 years, after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). One important aspect, highlighted by many global health organizations, is that this novel coronavirus outbreak may be especially hazardous to healthcare personnel, including laboratory professionals. Therefore, the aim of this document, prepared by the COVID-19 taskforce of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), is to provide a set of recommendations, adapted from official documents of international and national health agencies, on biosafety measures for routine clinical chemistry laboratories that operate at biosafety levels 1 (BSL-1; work with agents posing minimal threat to laboratory workers) and 2 (BSL-2; work with agents associated with human disease which pose moderate hazard). We believe that the interim measures proposed in this document for best practice will help minimazing the risk of developing COVID-19 while working in clinical laboratories.
- Subjects :
- Best practice
Pneumonia, Viral
Clinical Biochemistry
Medical laboratory
SARS-COV-2
01 natural sciences
Disease Outbreaks
Betacoronavirus
coronavirus disease 2019
03 medical and health sciences
Biosafety
0302 clinical medicine
Interim
Pandemic
Health care
medicine
Global health
Humans
030212 general & internal medicine
0101 mathematics
Pandemics
COVID-19
biosafety
laboratory
business.industry
010102 general mathematics
Biochemistry (medical)
General Medicine
Clinical Laboratory Services
Containment of Biohazards
medicine.disease
Coronavirus
Laboratory Personnel
Middle East respiratory syndrome
Medical emergency
Coronavirus Infections
Laboratories
business
Subjects
Details
- ISSN :
- 14374331 and 14346621
- Volume :
- 58
- Database :
- OpenAIRE
- Journal :
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Accession number :
- edsair.doi.dedup.....545054d553a07cf45d1b821fac78b56e